Home Deals Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Home Deals

- Clinical Trials
- Human Trials
July 24, 2018

Leap Therapeutics to evaluate TRX518/avelumab combo for advanced solid tumors

By PBR Staff Writer

TRX518 is a humanized monoclonal antibody with agonist activity that has been designed to target the glucocorticord-inducible TNF-superfamily receptor (GITR). The GITR agonist has been engineered to improve
Drug Discovery
Research & Development
July 24, 2018

Cambrex to buy Halo Pharma for $425m

By PBR Staff Writer

The acquisition will allow Cambrex to enter the dosage form CDMO market. Halo Pharma is majority owned by funds managed by the private investment firm SK Capital Partners.